Guiding principles for developing ACIP recommendations for vaccination during pregnancy and breastfeeding
Formulating policy to guide vaccination of women during pregnancy and breastfeeding is challenging because the evidence-base to guide decisions is extremely limited. In the past, ACIP has not provided guidance to workgroups on either the process to formulate policy for this population or the format and language for recommendations. As a result, workgroups have taken a variety of approaches to considering and presenting the issues, resulting in a diversity of recommendations that vary in clarity and underlying rationale. . The principles presented here provide guidance to help standardize both the process of policy formulation and the format and language of recommendations for pregnant and breastfeeding women. All ACIP statements about vaccines and other biologics for use in adolescents or adults should include a background section on vaccination during pregnancy and breastfeeding and provide explicit pregnancy and breastfeeding recommendations using standardized language as outlined below. To arrive at pregnancy and breastfeeding recommendations, ACIP workgroups or subject matter experts charged with developing vaccine statements should review the process suggestions outlined below. These suggestions, while similar to the process generally followed by workgroups, focus specifically on issues related to pregnancy, breastfeeding and decision making in the absence of a strong evidence-base.
1. This document and appendix provide a brief overview of specific issues related to vaccination during pregnancy and breastfeeding 2. Guidance for the pregnancy and breastfeeding background section a. Title: "Vaccination of women during pregnancy and breastfeeding" b. Scope: This section should address the following core topics with a narrow focus on the vaccine product/s in question i. In the context of pregnancy and breastfeeding, serious adverse reaction includes maternal, fetal or neonatal serious adverse events linked to the vaccine. Contraindication means that there is direct evidence or strong biologic plausibility and suggestive evidence that the risk of severe adverse event is elevated for at least one of these groups. Precaution means there is no supporting evidence but there is some biologic plausibility; precaution may also mean that there is a lack of data to support safety.
ii. 
